Kemnitzer; William E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kemnitzer; William E..The latest application filed is for "protease inhibitors for coronaviruses and sars-cov and the use thereof".

Company Profile

0.6.12

Kemnitzer; William E. - San Diego CA
Kemnitzer; William E. - Irvine CA
Kemnitzer; William E - Irvine CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof Grant 7,528,164 - Cai , et al. May 5, 2	2009-05-05
Protease inhibitors for coronaviruses and SARS-CoV and the use thereof Grant 7,504,382 - Cai , et al. March 17, 2	2009-03-17
Protease Inhibitors For Coronaviruses And Sars-cov And The Use Thereof App 20080300191 - Cai; Sui Xiong ; et al.	2008-12-04
Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis App 20080096848 - Kemnitzer; William E. ; et al.	2008-04-24
Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof App 20080085328 - Cai; Sui Xiong ; et al.	2008-04-10
3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof Grant 7,317,029 - Cai , et al. January 8, 2	2008-01-08
N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof App 20070213305 - Cai; Sui Xiong ; et al.	2007-09-13
Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof Grant 7,235,674 - Cai , et al. June 26, 2	2007-06-26
3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use of thereof App 20070112003 - Cai; Sui Xiong ; et al.	2007-05-17
N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof App 20070099877 - Cai; Sui Xiong ; et al.	2007-05-03
N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof App 20070099941 - Cai; Sui Xiong ; et al.	2007-05-03
3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof Grant 7,144,876 - Cai , et al. December 5, 2	2006-12-05
Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof App 20060104998 - Cai; Sui Xiong ; et al.	2006-05-18
Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof Grant 7,015,328 - Cai , et al. March 21, 2	2006-03-21
Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof App 20050090526 - Cai, Sui Xiong ; et al.	2005-04-28
Methods of treating diseases responsive to Induction of Apoptosis App 20050004005 - Kasibhatla, Shailaja ; et al.	2005-01-06
3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof App 20040127521 - Cai, Sui Xiong ; et al.	2004-07-01
Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof App 20030114485 - Cai, Sui Xiong ; et al.	2003-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.